Fresenius Medical Care AG (STU:FMEA) Cash per Share: €1.99 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:FMEA Fresenius Medical Care AG STU:FMEA
74 GF Score
Price €19.30
GF Value €20.99
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Cash per Share?

Fresenius Medical Care AG STU:FMEA +0.52% 74 Cash per Share is €1.99 as of Jun. 2026. GuruFocus rates STU:FMEA with a GF Score™ of 74/100 and a GF Value™ of €20.99 (Fairly Valued). The stock has 3 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Fresenius Medical Care AG's Cash per Share for the quarter that ended in Jun. 2026 was €1.99.

Fresenius Medical Care AG  (STU:FMEA) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Fresenius Medical Care AG Cash per Share Related Terms

Fresenius Medical Care AG Cash per Share Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Cash per Share Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.76 2.46 2.63 2.27 3.09

Fresenius Medical Care AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.92 2.17 3.09 2.29 1.99
STU:FMEA
74GF Score
Fresenius Medical Care AG STU:FMEA
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Fresenius Medical Care AG's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=1726.649/559
=3.09

Fresenius Medical Care AG's Cash per Share for the quarter that ended in Jun. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=1061.251/532
=1.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of €1.99 mean?
Fresenius Medical Care AG (STU:FMEA) has a Cash per Share of €1.99 as of Jun. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's Cash per Share too high?
Fresenius Medical Care AG's current Cash per Share is €1.99. Overall, Fresenius Medical Care AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Cash per Share compare to HCA and THC?
Fresenius Medical Care AG's Cash per Share of €1.99 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Healthcare Providers & Services company?
A good Cash per Share depends on the Healthcare Providers & Services industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Cash per Share is €1.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (STU:FMEA) is currently considered Fairly Valued. The stock's GF Value™ is €20.99, compared to a current price of €19.30 — trading 8.1% below its estimated fair value. The current Cash per Share is €1.99. Fresenius Medical Care AG's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Fresenius Medical Care AG (STU:FMEA), the current Cash per Share is €1.99 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (STU:FMEA) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of €19.30 is trading 8.1% below its estimated GF Value™ of €20.99. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for STU:FMEA:

  • Cash per Share: €1.99
  • GF Value™: €20.99 vs. price of €19.30 (8.1% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the STU:FMEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care AG is a German healthcare company focused on kidney care and dialysis. It operates two main segments: Health Care Services, which runs a global network of dialysis clinics treating patients with end-stage renal disease and related conditions, and Health Care Products, which manufactures and sells dialysis machines, dialyzers, filters, concentrates, and related medical technology. The company also provides renal pharmaceuticals, vascular access products, and home dialysis therapies. Services generate the majority of revenue, primarily through reimbursement from public and private payers, while product sales contribute the remainder. Fresenius Medical Care operates clinics and production sites across North America, Europe, the Middle East, Africa, Asia-Pacific, and Latin America, with the United States representing its largest market. The company is headquartered in Bad Homburg, Germany, and its shares trade on the Frankfurt Stock Exchange and the New York Stock Exchange.
74GF Score

Get the complete analysis for STU:FMEA

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.30
Price
€20.99
GF Value